IRX Therapeutics Contact IRX TherapeuticsIRX Therapeutics
ABOUT IRX SCIENCE & TECHNOLOGY PRODUCT CANDIDATES CLINICAL TRIALS NEWS & EVENTS

Latest News

Neil L. Berinstein, M.D. Joins IRX Team
IRX Therapeutics appoints Neil L. Berinstein, M.D. Chief Scientific Officer

IRX Presents Phase 2 Results
IRX Therapeutics to Present Phase 2 Results at 7th International Conference on Head and Neck Cancer

IRX Therapeutics to Present Phase 2b Results
IRX Therapeutics to Present Phase 2b Results at 3rd European Conference on Head & Neck Oncology


 

IRX Facts
Fact Sheet
IRX is pioneering a breakthrough approach to fight cancer and viral disease. The Company’s proprietary technologies stimulate dendritic cells, macrophages, and T-cells by initiating a Th1-specific cellular immune response.
© 2009 IRX Therapeutics
Site Design: DKB Marketing